PMAM
RAPT

Picton Mahoney Asset Management’s RAPT Therapeutics RAPT Stock Holding History

Picton Mahoney Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,022
Closed -$26K – 1010
2024
Q4 		$26K Buy
2,022
+1,837
+993% +$23.3K ﹤0.01% 519
2024
Q3 		$3K Buy
185
+131
+243% +$2.65K ﹤0.01% 561
2024
Q2 		$1K Buy
+54
New +$2.49K ﹤0.01% 581

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Picton Mahoney Asset Management's RAPT Position: Q1 2025 in Review

Picton Mahoney Asset Management sold out of RAPT Therapeutics (RAPT) in Q1 2025, closing a stake of 2,022 shares — an estimated $26K sold.

Picton Mahoney Asset Management first reported a position in RAPT in Q2 2024 and held it in 3 quarters. The position peaked at $26K in Q4 2024. 92 funds tracked by Wall St. Rank hold RAPT as of Q1 2025.

  • Picton Mahoney Asset Management reported no remaining RAPT Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 2,022 RAPT Therapeutics shares in Q1 2025, an estimated $26K.
  • Picton Mahoney Asset Management first reported a position in RAPT Therapeutics in Q2 2024 and held it in 3 quarters.
  • Picton Mahoney Asset Management's RAPT Therapeutics position peaked at $26K in Q4 2024.
  • 92 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2025, filed 7 May 2025.